Sr. Global Manager, Qiagen
Dr. Krishnan Allampallam has spent over 15 years in the biotech industry. Before joining the industry, Dr. Allampallam worked on pathophysiology of myelodysplastic syndrome and has authored / co-authored multiple publications, abstracts and book chapters. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center before moving to biotech. He has been at QIAGEN since 2008.